What you don’t know about Martin Shkreli — his investing tips and strategies By: MarketWatch September 07, 2017 at 00:01 AM EDT The ‘pharma bro’ might be mired in controversy, but he has valuable investing insights, writes Michael Brush. Read More >> Related Stocks: Acadia Pharmaceutica Apple Astrazeneca Plc ADR Biomarin Pharmaceuticals Bristol-Myers Squibb Eli Lilly Incyte Corp Merck & Co Nasdaq Biotechnology Ishares ETF Netflix Roche Holding AG Basel American Depositary Shares Sangamo Therapeutics Spark Therap Tesla, Inc. Uniqure Ord Shs